Relmada Therapeutics Inc. (RLMD)
RLMD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.36
-4.27% on the day
Market cap
$358.4M
Small cap
Revenue
No annual revenue filed since the period ending 2013-08-31
Net income
No annual revenue filed since the period ending 2013-08-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | RLMD on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001553643 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials
No annual revenue filed since the period ending 2013-08-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | S-3ASR | 2026-05-13 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-19 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-06 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-08 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-04-17 |
Source: SEC EDGAR submissions feed, 606 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.1% |
| 1 month | -27.6% |
| 3 months | -41.1% |
| Year to date | -33.4% |
| 1 year | +59.2% |
| From 52-week high | -59.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | $6.91 | -1.00% | $354.3M |
| IRD | Opus Genetics Inc. | $4.24 | -8.62% | $352.8M |
| GALT | Galectin Therapeutics Inc. | $3.69 | -4.65% | $372.9M |
| ARCT | Arcturus Therapeutics Holdings Inc. | $12.03 | -4.60% | $341.9M |
| ENTA | Enanta Pharmaceuticals Inc. | $11.52 | -6.34% | $335.5M |
| AVIR | Atea Pharmaceuticals Inc. | $4.98 | -0.99% | $399.4M |
| CAPR | Capricor Therapeutics Inc. | $6.88 | -7.90% | $400.0M |
| SPRY | ARS Pharmaceuticals Inc. | $4.05 | -3.11% | $402.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier